Ultralife Corp ULBI Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$6.05 down $0.06, 0.98% on Oct 16
Last price · Previous close $6.11
- Market cap
- At the last price
- P/E ratio
- n/mLoss over last 12 months
- Diluted EPS
- −$0.39Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$6.05down $0.06, 0.98%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$6.11Oct 15
- Volume19.79KOct 15 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume37.51KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $4.90 to $8.25; now $6.05
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the last price. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
ULBI beat the S&P 500 in 2 of 7 periods.
| Period | ULBI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | ULBI: up 11.0% S&P 500: up 1.5% | ULBI beat the S&P 500 by 9.5 percentage points Beat |
| 3M | ULBI: up 9.0% S&P 500: up 1.9% | ULBI beat the S&P 500 by 7.1 percentage points Beat |
| YTD | ULBI: up 5.8% S&P 500: up 12.8% | ULBI trailed the S&P 500 by 7.0 percentage points Trailed |
| 1Y | ULBI: down 11.3% S&P 500: up 16.8% | ULBI trailed the S&P 500 by 28.1 percentage points Trailed |
| Long term | ||
| 3Y | ULBI: down 45.9% S&P 500: up 81.5% −18.5% vs +22.0% a year | ULBI trailed the S&P 500 by 127.4 percentage points Trailed |
| 5Y | ULBI: down 14.8% S&P 500: up 83.1% −3.2% vs +12.9% a year | ULBI trailed the S&P 500 by 97.9 percentage points Trailed |
| 10Y | ULBI: up 48.6% S&P 500: up 319.6% +4.0% vs +15.4% a year | ULBI trailed the S&P 500 by 271.0 percentage points Trailed |
$10,000 invested in ULBI 10 years ago (Oct 14, 2016) would be worth about $14,865 as of , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,964.
ULBI beat the S&P 500 in 2 of 7 periods.
| Period | ULBI and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | ULBI: up 11.0% S&P 500: up 1.2% | ULBI beat the S&P 500 by 9.8 percentage points Beat |
| 3M | ULBI: up 9.0% S&P 500: up 1.7% | ULBI beat the S&P 500 by 7.3 percentage points Beat |
| YTD | ULBI: up 5.8% S&P 500: up 11.9% | ULBI trailed the S&P 500 by 6.1 percentage points Trailed |
| 1Y | ULBI: down 11.3% S&P 500: up 15.5% | ULBI trailed the S&P 500 by 26.8 percentage points Trailed |
| Long term | ||
| 3Y | ULBI: down 45.9% S&P 500: up 75.0% −18.5% vs +20.5% a year | ULBI trailed the S&P 500 by 120.9 percentage points Trailed |
| 5Y | ULBI: down 14.8% S&P 500: up 71.2% −3.2% vs +11.4% a year | ULBI trailed the S&P 500 by 86.0 percentage points Trailed |
| 10Y | ULBI: up 48.6% S&P 500: up 258.1% +4.0% vs +13.6% a year | ULBI trailed the S&P 500 by 209.5 percentage points Trailed |
$10,000 invested in ULBI 10 years ago (Oct 14, 2016) would be worth about $14,865 as of , not counting dividends. The same amount in the S&P 500 would be worth about $35,813.
All-time high
$24.50
Closing high on . Now 75.3% below that record.
Split-adjusted daily closes since Dec 23, 1992.
Stock splits
ULBI hasn’t split since its price history begins in 1992.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q2 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $187.24Mup 4.7%
- Net income
- −$6.55M
- Diluted EPS
- −$0.39
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q3 FY24 (Sep 30, 2024) | $35.69M | $258.00K | $0.02 |
| Q4 FY24 (Dec 31, 2024) | $43.85M | $194.00K | $0.01 |
| Q1 FY25 (Mar 31, 2025) | $50.75M | $1.87M | $0.11 |
| Q2 FY25 (Jun 30, 2025) | $48.56M | $879.00K | $0.05 |
| Q3 FY25 (Sep 30, 2025) | $43.37M | −$1.22M | −$0.07 |
| Q4 FY25 (Dec 31, 2025) | $48.48M | −$7.42M | −$0.44 |
| Q1 FY26 (Mar 31, 2026) | $47.45M | −$451.00K | −$0.03 |
| Q2 FY26 (Jun 30, 2026) | $47.94M | $2.54M | $0.15 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $98.27M | −$234.00K | −$0.01 |
| FY22 (Dec 31, 2022) | $131.84M | −$119.00K | −$0.01 |
| FY23 (Dec 31, 2023) | $158.64M | $7.20M | $0.44 |
| FY24 (Dec 31, 2024) | $164.46M | $6.31M | $0.38 |
| FY25 (Dec 31, 2025) | $191.16M | −$5.90M | −$0.35 |
Margins
- Gross 24.4%
- Operating −4.5%
- Net −3.5%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $2.03MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$5.13MLast 12 months
- Capital spending$3.10MLast 12 months
- 1.1%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $73.00KLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$0.00Last 12 months
0% of free cash flow
Balance sheet
- $6.66MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$44.60MAs of Jun 30, 2026
- Net debt$37.94MAs of Jun 30, 2026
- 2.87As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.34As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 3 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✗Net income was positive: not passed
- ✓Operating cash flow was positive: passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✗Share count didn’t rise: not passed
- ✗Gross margin improved: not passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- −4.9%Last 12 months
Over the last 12 months, Ultralife lost money: its net loss was 4.9% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −3.0%Last 12 months
Over the last 12 months, Ultralife’s net loss was 3.0% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About Ultralife Corp
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe. Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia.
- Sector
- Industrials
- Industry
- Electrical Equipment & Parts
- Headquarters
- New York, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
ULBI news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
ULBI stock FAQ
What is ULBI stock’s price today?
Ultralife (ULBI) traded at $6.05 as of , down $0.06 (0.98%) from the previous close of $6.11. Over the past 52 weeks it has traded between $4.90 and $8.25.
If you invested $1,000 in ULBI 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in ULBI on would be worth about $1,486 as of , a total return of +48.6%. The same $1,000 would be worth $852 if invested five years ago, $887 if invested one year ago, $448 if invested 20 years ago, and $550 if invested 30 years ago. Past performance doesn’t predict future returns.
What is ULBI’s P/E ratio?
ULBI’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$0.39).
How much revenue does Ultralife make?
Ultralife reported $187.2 million of revenue over the four quarters to , up 4.7% from the twelve months before. In its latest quarter (Q2 FY26, ended ) revenue was $47.9 million, down 1.3% from a year earlier.
Is Ultralife profitable?
Not over the four quarters to . Ultralife reported a net loss of $6.6 million across those four quarters on $187.2 million of revenue.
What are ULBI’s earnings per share?
ULBI’s diluted earnings per share were −$0.39 over the four quarters to , compared with $0.19 in the twelve months before. The latest quarter (Q2 FY26) brought $0.15 per share, against $0.05 a year earlier (how EPS works).
Does ULBI pay a dividend?
Ultralife hasn’t paid a dividend in the last twelve months.
What is ULBI’s 52-week high and low?
Over the past 52 weeks ULBI has traded as low as $4.90 and as high as $8.25. At $6.05 as of , it is 26.7% below that high and 23.5% above the low.
What is ULBI’s all-time high?
ULBI’s highest closing price was $24.50 on , adjusted for stock splits. At $6.05 as of , it is 75.3% below that record.
Has ULBI stock ever split?
No. ULBI hasn’t split since its price history begins in 1992.
How has ULBI stock performed?
Including dividends and measured to the last price on , ULBI has returned +5.8% so far this year and −11.3% over the past year, and −14.8% over five years (−3.2% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What sector and industry is Ultralife in?
Ultralife is in the Industrials sector and the Electrical Equipment & Parts industry, and is headquartered in New York, USA.
What exchange does ULBI trade on?
Ultralife trades on the Nasdaq under the ticker symbol ULBI. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.